Variation in anthelmintic responses are driven by genetic differences among diverse C. elegans wild strains
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011285 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Amanda O Shaver und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biosciences, Northwestern University, Evanston, Illinois, United States of America. Hauptthemen laut MEDLINE: Anthelmintics, Nematoda, Nematode Infections. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Treatment of parasitic nematode infections in humans and livestock relies on a limited arsenal of anthelmintic drugs that have historically reduced parasite burdens. However, anthelmintic resistance (AR) is increasing, and little is known about the molecular and genetic causes of resistance for most drugs. The free-living roundworm Caenorhabditis elegans has proven to be a tractable model to understand AR, where studies have led to the identification of molecular targets of all major anthelmintic drug classes. Here, we used genetically diverse C . elegans strains to perform dose-response analyses across 26 anthelmintic drugs that represent the three major anthelmintic drug classes (benzimidazoles, macrocyclic lactones, and nicotinic acetylcholine receptor agonists) in addition to seven other anthelmintic classes. First, we found that C . elegans strains displayed similar anthelmintic responses within drug classes and significant variation across drug classes. Next, we compared the effective concentration estimates to induce a 10% maximal response (EC 10 ) and slope estimates of each dose-response curve of each strain to the laboratory reference strain, which enabled the identification of anthelmintics with population-wide differences to understand how genetics contribute to AR. Because genetically diverse strains displayed differential susceptibilities within and across anthelmintics, we show that C . elegans is a useful model for screening potential nematicides before applications to helminths. Third, we quantified the levels of anthelmintic response variation caused by genetic differences among individuals (heritability) to each drug and observed a significant correlation between exposure closest to the EC 10 and the exposure that exhibited the most heritable responses. These results suggest drugs to prioritize in genome-wide association studies, which will enable the identification of AR genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.
- Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
ORCID-Profile: Amanda O Shaver, Erik C Andersen
Förderung
- NIAID NIH HHS
Zitieren
APA
Shaver, A. O., Wit, J., Dilks, C. M., Crombie, T. A., Li, H., Aroian, R. V., & Andersen, E. C. (2023). Variation in anthelmintic responses are driven by genetic differences among diverse C. elegans wild strains. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011285
Vancouver
Shaver AO, Wit J, Dilks CM, Crombie TA, Li H, Aroian RV, et al. Variation in anthelmintic responses are driven by genetic differences among diverse C. elegans wild strains. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011285
BibTeX
@article{Shaver2023,
author = {Shaver, Amanda O and Wit, Janneke and Dilks, Clayton M and Crombie, Timothy A and Li, Hanchen and Aroian, Raffi V and Andersen, Erik C},
title = {Variation in anthelmintic responses are driven by genetic differences among diverse C. elegans wild strains},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011285}
}
EUVIMED